Mrs Maureen Sullivan Evans, MS CCC-SLP in Baldwin, MD - Speech-Language Pathologist

Mrs Maureen Sullivan Evans, MS CCC-SLP is a Speech-language Pathologist based in Baldwin, Maryland. Mrs Maureen Sullivan Evans is licensed to practice in Maryland (license number 07140) and her current practice location is 2608 Stanley Dr, Baldwin, Maryland. She can be reached at her office (for appointments etc.) via phone at (443) 243-3628.

NPI number for Mrs Maureen Sullivan Evans is 1255691523 and her current mailing address is 2608 Stanley Dr, Baldwin, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1255691523.

Contact Information

	Mrs Maureen Sullivan Evans, MS CCC-SLP
	2608 Stanley Dr, Baldwin, MD 21013-9134
	(443) 243-3628
	Not Available

Healthcare Provider's Profile

Full Name	Mrs Maureen Sullivan Evans
Gender	Female
Speciality	Speech-language Pathologist
Location	2608 Stanley Dr, Baldwin, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1255691523
Provider Enumeration Date: 05/21/2012
Last Update Date: 02/28/2019

Medical Identifiers

Medical identifiers for Mrs Maureen Sullivan Evans such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1255691523	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	07140 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Maureen Sullivan Evans is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Maureen Sullivan Evans, MS CCC-SLP 2608 Stanley Dr, Baldwin, MD 21013-9134 Ph: (443) 243-3628	Mrs Maureen Sullivan Evans, MS CCC-SLP 2608 Stanley Dr, Baldwin, MD 21013-9134 Ph: (443) 243-3628

News Archive

WVU researchers develop viable alternatives to N95 masks

The novel coronavirus pandemic has nearly exhausted stockpiles of medical gear in the United States. Personal protective equipment, like masks, serve as a first-line defense for medical professionals with a front row seat to COVID-19.

SVR associated with prolonged overall survival in patients with chronic HCV infection

Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with a lower risk of all-cause mortality compared with patients without SVR, according to a study in the December 26 issue of JAMA.

DealSearchOnline.com announces $72.3B committed to fund 291 managed care mergers and acquisitions

More than $72.3 billion was committed to fund 291 managed care mergers and acquisitions announced during the 10-year period ended December 31, 2009, according to DealSearchOnline.com. UnitedHealth Group was the acquirer in 10 of the top 25 managed care mergers and acquisitions announced during 10-year period ended December 31, 2009.

Novartis informs Emisphere on First Interpretable Results of two-year Phase III Study 2301 in osteoarthritis

Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).

Genzyme, Arecor establish strategic partnership for developing advanced protein therapeutic formulations

Genzyme Corporation and Arecor Limited today signed an agreement providing for extensive collaboration on developing advanced formulations for protein therapeutics. The agreement provides for a close working relationship between Genzyme and Arecor in developing stable, high strength formulations of labile biomolecules. This agreement is the result of a two year working relationship where Arecor has demonstrated their technologies offer an improvement over conventional approaches in protein formulation.

Speech-Language Pathologist in Baldwin, MD

Mrs. Laura Elizabeth Keeney, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13609 Devonbrook Rd, Baldwin, MD 21013 Phone: 410-598-9914
Judith Ann Heller, MSCCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13 Manor Knoll Ct, Baldwin, MD 21013 Phone: 410-952-3724

Mrs Maureen Sullivan Evans, MS CCC-SLP - Speech-Language Pathologist in Baldwin, MD